SCHEMBL12874912

SCHEMBL12874912

CC1(C(=O)Nc2ccc(CC(F)(F)F)cc2)CCN(Cc2ccccc2Cl)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.48
▸ MAPT P10636 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ PKM P14618 1/20 0.44
▸ DCUN1D1 Q96GG9 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ SLC2A1 P11166 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ OPRD1 P41143 1/20 0.42
▸ DRD2 P14416 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12875147 0.89 MEN1 (0.51) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL12875146 0.82 MEN1 (0.43) FAAHSMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL12874915 0.82 EPHX2 (0.52) LMNASMN1; SMN2RAB9AKMT2AGAA
SCHEMBL12875314 0.77 KDM4E (0.47) FAAHMEN1KMT2APOLBGAA
SCHEMBL1147279 0.76 MAPT (0.53) FAAHMAPTLMNASMN1; SMN2RAB9A
SCHEMBL1146747 0.75 FAAH (0.50) FAAHMAPTLMNASMN1; SMN2RAB9A
SCHEMBL12875143 0.75 CNR2 (0.49) FAAHTP53GAA
SCHEMBL12875690 0.75 CHRNB2 (0.50) MAPTSMN1; SMN2MEN1KMT2APKM
SCHEMBL1147286 0.75 MAPT (0.54) FAAHMAPTLMNAOPRM1OPRD1
SCHEMBL1146884 0.73 FAAH (0.50) FAAHMAPTLMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012602-A1 PIPERIDINE DERIVATIVES AND THEIR USE TO TREAT OBESITY, DIABETES, DYSLIPIDEMIA AND ATHEROSCLEROSIS F. HOFFMANN-LA ROCHE AG (CH) 2011-02-03 — — WO disclosed
Send feedback